(Q73437037)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

A A Boyt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

T K Taddei

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J Hallmayer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

E Helmerhorst

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S E Gandy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Craft

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

727-734

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

Isoform-specific modulation by apolipoprotein E of the activities of secreted beta-amyloid precursor protein

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Amyloid beta peptide induces necrosis rather than apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Hydrogen peroxide mediates amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

An abnormality of plasma amyloid protein precursor in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Platelets Are the Primary Source of Amyloid β-Peptide in Human Blood

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Glucose and memory in mild senile dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Memory improvement following induced hyperinsulinemia in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Positron emission tomography in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Regional cerebral glucose transport and utilization in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Apolipoprotein E forms stable complexes with recombinant Alzheimer's disease beta-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Non-insulin-dependent diabetes mellitus and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Protein inhibitors of proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

The risk of dementia among persons with diabetes mellitus: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Proteolytic processing of Alzheimer's disease beta A4 amyloid precursor protein in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

The molecular pathology of amyloid deposition in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Alterations in glucose metabolism in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Human brain beta A4 amyloid protein precursor of Alzheimer's disease: purification and partial characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

The molecular pathogenesis of Alzheimer's disease: clinical prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Isoform-specific binding of human apolipoprotein E to the non-amyloid beta component of Alzheimer's disease amyloid.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Association of diabetes mellitus and dementia: the Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Antisera to an amino-terminal peptide detect the amyloid protein precursor of Alzheimer's disease and recognize senile plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Soluble derivatives of the beta amyloid protein precursor of Alzheimer's disease are labeled by antisera to the beta amyloid protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Characterization of an amyloid beta precursor protein that binds heparin and contains tyrosine sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Hypoglycemia enhances the expression of mRNA encoding beta-amyloid precursor protein in rat primary cortical astroglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Advanced glycation endproducts-associated parameters in the peripheral blood of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Amyloid precursor protein requires the insulin signaling pathway for neurotrophic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Apolipoprotein E genotyping by one-stage PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Collection and normal levels of the amyloid precursor protein in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Age at onset and regional cerebral glucose metabolism in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

A heparin-binding protein from neuroblastoma cells: Immunological comparison to β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900458-3

7 January 2021

10.1016/S0306-4522(99)00458-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10670439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference